Business
Precision BioSciences Stock Rally ahead of Q3 2023 Results
Precision BioSciences, a cutting-edge gene editing company specializing in innovative in vivo gene editing therapies through its proprietary ARCUS® platform, declared today its intention to...
FTC Urged to Examine Exxon Mobil, Chevron Mergers Amidst Antitrust Concerns
US Senate Majority Leader Charles Schumer has voiced apprehensions regarding the recent acquisitions of Exxon Mobil and Chevron Corp., marking them as two of the...
ZyVersa Therapeutics Stock Surges on Breakthrough MS Research
ZyVersa Therapeutics, a clinical stage specialty biopharmaceutical company specializing in the development of first-in-class drugs for the treatment of inflammatory and renal diseases, has announced...
Monopar Therapeutics Stock Surges Ahead of Ongoing ASTS Clinical Trial Data Release
Monopar Therapeutics, a clinical-stage biopharmaceutical company dedicated to advancing proprietary therapeutics aimed at enhancing the longevity and quality of life for cancer patients, is set...
Aldeyra Therapeutics’ Stock Surges Over 50 % as Exclusive Option Agreement with AbbVie Unveiled
In a significant development, Aldeyra Therapeutics, a leading biotechnology company specializing in the discovery and development of innovative therapies for immune-mediated diseases, announced today that...
La Rosa Holdings’ Agent Incentive Plan Triggers Market Reaction
La Rosa Holdings, a conglomerate overseeing seven agent-centric, tech-integrated, cloud-based real estate firms, reported on its La Rosa Holdings 2022 Agent Incentive Plan yesterday. The...
Lumen Technologies Reports Q3 2023 Results, Stock Declines
Lumen Technologies, Inc. released its financial results for the third quarter (Q3) of 2023, revealing an adjusted loss per share (excluding special items) of 9...
Motus GI Initiates 1-for-15 Reverse Stock Split to Meet Nasdaq Listing Requirements
Motus GI Holdings, a leading medical technology firm dedicated to enhancing endoscopic outcomes and patient experiences, made a significant announcement today regarding a 1-for-15 reverse...
CVS Health Q3 Results Surpass Wall Street Estimates
CVS Health reported impressive third-quarter (Q3) results, surpassing Wall Street’s estimates. Despite facing higher-than-projected medical costs in its health insurance arm, the company’s strong performance...
IRIDEX Corp Faces Steep Decline in Stock Market Performance
IRIDEX Corp, a leading provider of cutting-edge ophthalmic laser-based medical solutions specializing in the treatment of glaucoma and retinal diseases, is grappling with a significant...
